Last edition
News about "Joe Hazelton"
Dyadic Applied BioSolutions has entered into a commercial partnership with Opes to accelerate adoption of its recombinant growth factors and media proteins, leveraging Opes’ market presence in Europe, Israel and Asia, while retaining Dyadic’s ability to sell directly and engage additional partners, globally.
Joe Hazelton | 16/12/2025 | By News Bureau | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members